The investigators observed the level of IL-35 secreting B regulatory (IL-35+Bregs) cells in peripheral blood cells in patients with chronic hepatitis B, and analysed the relationship between the IL-35+Bregs level and disease stage, and Th1 and Th2 cells level.
Regulatory B cells (Bregs) are involved in the immune tolerance process through multiple pathways and Bregs are involved in the process of chronic HBV infection. Here the investigators intended to investigate the regulating role and the mechanism of CD19+ IL-35+ cells on host T cell immune during chronic HBV infection by using in vitro cell sorting, B cell differentiation induction, Transwell cell co-culture system and other methods.
Study Type
OBSERVATIONAL
Enrollment
55
Changhai hospital
Shanghai, China
IL-35+Bregs level
IL-35 secreting regulatory B cells level in patients with CHB
Time frame: ENROLLED DAY
IL-35+Bregs regulatory effect
regulatory effect of IL-35+Bregs on T cell immune
Time frame: enrolled day
IL-35+Bregs phenotype
the main phenotype of IL-35 secreting Bregs
Time frame: enrolled day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.